Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome

Severe cases of COVID‐19 infection, often leading to death, have been associated with variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal stromal cells (MSCs) is a potential treatment for COVID‐19 ARDS based on preclinical and clinical studies supporting the concept...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Wenchun, Wang, Zhen, Hare, Joshua M., Bu, Guojun, Mallea, Jorge M., Pascual, Jorge M., Caplan, Arnold I., Kurtzberg, Joanne, Zubair, Abba C., Kubrova, Eva, Engelberg‐Cook, Erica, Nayfeh, Tarek, Shah, Vishal P., Hill, James C., Wolf, Michael E., Prokop, Larry J., Murad, M. Hassan, Sanfilippo, Fred P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Concise Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300743/
https://www.ncbi.nlm.nih.gov/pubmed/32472653
http://dx.doi.org/10.1002/sctm.20-0146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300743/
https://www.ncbi.nlm.nih.gov/pubmed/32472653
http://dx.doi.org/10.1002/sctm.20-0146

Ejemplares similares